N-3 epoxy fatty acids (EpFAs) are bioactive metabolites generated by cytochrome P-450 (CYP450) epoxygenases from n-3 polyunsaturated fatty acids (PUFAs). 17,18-Epoxyeicosatetraenoic acids (17,18-EEQ) and 19,20-epoxydocosapentaenoic acids (19,20-EDP) are the major EpFAs derived from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), respectively. Epoxy-fatty-acids modulate angiogenesis, vascular dilation, inflammation, and cell growth and differentiation, and are implicated in tumor growth and metastasis, cardiovascular disease, diabetes, metabolic syndromes, and pain. Many of the beneficial effects of these EpFAs were potentiated by co-administration of an sEH inhibitor
Type : Epoxy-fatty-acid, Epoxide, Fatty acid
Chemical_Nomenclature : (5Z,8Z,11Z,14Z)-16-[(2R,3S)-3-ethyloxiran-2-yl]hexadeca-5,8,11,14-tetraenoic acid, (5Z,8Z,11Z,14Z)-16-[(2S,3R)-3-ethyloxiran-2-yl]hexadeca-5,8,11,14-tetraenoic acid
Canonical SMILES : CCC1C(O1)CC=CCC=CCC=CCC=CCCCC(=O)O
InChI : InChI=1S\/C20H30O3\/c1-2-18-19(23-18)16-14-12-10-8-6-4-3-5-7-9-11-13-15-17-20(21)22\/h3,5-6,8-9,11-12,14,18-19H,2,4,7,10,13,15-17H2,1H3,(H,21,22)\/b5-3-,8-6-,11-9-,14-12-\/t18-,19+\/m0\/s1 || InChI=1S\/C20H30O3\/c1-2-18-19(23-18)16-14-12-10-8-6-4-3-5-7-9-11-13-15-17-20(21)22\/h3,5-6,8-9,11-12,14,18-19H,2,4,7,10,13,15-17H2,1H3,(H,21,22)\/b5-3-,8-6-,11-9-,14-12-\/t18-,19+\/m1\/s1
InChIKey : GPQVVJQEBXAKBJ-VDTDYMMTSA-N || GPQVVJQEBXAKBJ-YQLHGUCYSA-N
Other name(s) : 17,18-Epoxyeicosatetraenoic acid || 17R,18S-EpETE || 17(R),18(S)-EETeTr || CHEBI:76953 || (5Z,8Z,11Z,14Z)-(17R,18S)-17,18-Epoxyicosa-5,8,11,14-tetraenoic acid || 17R,18S-epoxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid || CHEMBL1802675 || (+\/-)17(18)-EpETE || 17(S),18(R)-EETeTr || CHEBI:76955 || 17,18-EETeTr || 17(18)-epoxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid || CHEMBL1802676
MW : 318.4
Formula : C20H30O3
CAS_number :
UniChem : GPQVVJQEBXAKBJ-VDTDYMMTSA-N, GPQVVJQEBXAKBJ-YQLHGUCYSA-N
Structures : No structure
Families : Epoxide_hydrolase
Title : Differential Effects of 17,18-EEQ and 19,20-EDP Combined with Soluble Epoxide Hydrolase Inhibitor t-TUCB on Diet-Induced Obesity in Mice - Yang_2021_Int.J.Mol.Sci_22_ |
Author(s) : Yang Y , Xu X , Wu H , Yang J , Chen J , Morisseau C , Hammock BD , Bettaieb A , Zhao L |
Ref : Int J Mol Sci , 22 : , 2021 |
Abstract : |
PubMedSearch : Yang_2021_Int.J.Mol.Sci_22_ |
PubMedID: 34361032 |
Title : Epoxy Fatty Acids Are Promising Targets for Treatment of Pain, Cardiovascular Disease and Other Indications Characterized by Mitochondrial Dysfunction, Endoplasmic Stress and Inflammation - McReynolds_2020_Adv.Exp.Med.Biol_1274_71 |
Author(s) : McReynolds C , Morisseau C , Wagner K , Hammock B |
Ref : Advances in Experimental Medicine & Biology , 1274 :71 , 2020 |
Abstract : |
PubMedSearch : McReynolds_2020_Adv.Exp.Med.Biol_1274_71 |
PubMedID: 32894508 |